Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04118036 |
|---|---|
| Brief Title: | Abemaciclib + Pembrolizumab In Glioblastoma |
| First Submitted : | October 4, 2019 |
| First Submitted that Met QC Criteria : | October 4, 2019 |
| First Posted : | October 7, 2019 |
| Last Update Submitted that Met QC Criteria : | December 13, 2021 |
| Last Update Posted : | December 14, 2021 |